Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

GLICLAZIDE MR

SANIS HEALTH INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is GLICLAZIDE MR discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that GLICLAZIDE MR 30MG has been permanently discontinued (last updated January 6, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is GLICLAZIDE MR not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file6 products · 5 same form & route
Affected strength30MG
Report last updated2026-01-06
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

DIAMICRON MR

SERVIER CANADA INC

30MG · DIN 02242987

Same strengthSame dosage formSame routeNo current shortage

JAMP GLICLAZIDE-MR

JAMP PHARMA CORPORATION

30MG · DIN 02429764

Same strengthSame dosage formSame routeNo current shortage

TARO-GLICLAZIDE MR

SUN PHARMA CANADA INC

30MG · DIN 02463571

Same strengthSame dosage formSame routeNo current shortage

MYLAN-GLICLAZIDE MR

MYLAN PHARMACEUTICALS ULC

30MG · DIN 02438658

Same strengthSame dosage formSame routeNo current shortage

AG-GLICLAZIDE MR

ANGITA PHARMA INC.

30MG · DIN 02483300

Same strengthSame dosage formSame routeNo current shortage

Other Products

TEVA-GLICLAZIDE

TEVA CANADA LIMITED

80MG · DIN 02238103

Different strengthDifferent dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

DIN

02524856

Strength

30MG

Dosage Form

TABLET (EXTENDED-RELEASE)

Route

ORAL

Active Ingredient

GLICLAZIDE

See all GLICLAZIDE products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History